Journal article
NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia – A brief report from the ORIGIN trial
Abstract
In patients with diabetes and cardiovascular or renal comorbidities, circulating levels of the N-terminal fragment of prohormone B-type natriuretic peptide (NT-proBNP) have similar discriminatory ability as multivariate models for prediction of cardiovascular events or death. We validated this finding in patients with dysglycemia not selected for co-existing cardiorenal diseases.
Authors
Wijkman MO; Claggett BL; Pfeffer MA; Paré G; McQueen M; Hess S; Lee SF; Gerstein HC
Journal
Journal of Diabetes and its Complications, Vol. 35, No. 7,
Publisher
Elsevier
Publication Date
July 2021
DOI
10.1016/j.jdiacomp.2021.107928
ISSN
1056-8727